Douglas A. Treco, Ph.D.
Lead Independent DirectoratCRISPR Therapeutics AG· In proxies 2023–2025
Douglas A. Treco, Ph.D. sits on 1 public board.
Boards1
- CRISPR Therapeutics AGLead independent director · 3 yr on the boardIndependentAudit, Directors and Executive, Nominating and Corporate Governance—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- CRISPR Therapeutics AGPublic company · 3 yr
- Lead Independent Director2023 – Present · 3 yrStock in role +32%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?